Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
A Bull Market Is Coming: 2 Smart Reasons to Buy Tesla Stock Right Now
If you’re seeking a way to profit from the soaring adoption of electric vehicles (EVs) around the world, look no further than Tesla (NASDAQ: TSLA).
Here’s a New Million-Dollar Reason to Buy CRISPR Therapeutics
CRISPR Therapeutics (NASDAQ: CRSP) is heading for an important moment: the potential approval of its first product, exa-cel to treat blood disorders. That’s a good
Little Rock picks up the pieces after deadly tornado pummels central Arkansas
By Liliana Salgado LITTLE ROCK, Arkansas, April 1 (Reuters) – Arkansas first responders will sift through rubble on Saturday, searching for more possible victims after
The Average Social Security Beneficiary Has Been Cheated Out of $6,478 in Annual Income
Whether you’re already retired and receiving a Social Security benefit or preparing to enter the workforce for many decades to come, there’s a good chance
CJS Securities Initiates Coverage of RadNet (RDNT) with Outperform Recommendation
On March 31, 2023, CJS Securities initiated coverage of RadNet with a Outperform recommendation. Analyst Price Forecast Suggests 18.18% Upside As of March 31, 2023,
B. Riley Securities Initiates Coverage of Silk Road Medical (SILK) with Buy Recommendation
On March 31, 2023, B. Riley Securities initiated coverage of Silk Road Medical with a Buy recommendation. Analyst Price Forecast Suggests 46.50% Upside As of
Mizuho Initiates Coverage of Immunocore Holdings (IMCR) with Buy Recommendation
On March 31, 2023, Mizuho initiated coverage of Immunocore Holdings with a Buy recommendation. Analyst Price Forecast Suggests 67.32% Upside As of March 30, 2023,
Craig-Hallum Initiates Coverage of Integral Ad Science Holding (IAS) with Buy Recommendation
On March 31, 2023, Craig-Hallum initiated coverage of Integral Ad Science Holding with a Buy recommendation. Analyst Price Forecast Suggests 4.54% Upside As of March
Stephens & Co. Initiates Coverage of 10x Genomics, Inc. (TXG) with Overweight Recommendation
On March 31, 2023, Stephens & Co. initiated coverage of 10x Genomics, Inc. with a Overweight recommendation. Analyst Price Forecast Suggests 5.48% Downside As of
Mizuho Initiates Coverage of Immatics (IMTX) with Buy Recommendation
On March 31, 2023, Mizuho initiated coverage of Immatics with a Buy recommendation. Analyst Price Forecast Suggests 164.86% Upside As of March 30, 2023, the